Our results showing a significant downregulation of DNAM-1 and a higher expression of TIGIT in AML patients suggest that these alterations may be, at least in part, involved in the decreased effector functions of cytotoxic cells in these patients [38]. This evidence concerns the gene CD226 and acute myeloid leukemia.